DBVT Q4 2016 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q4 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+0.1% YoY

Gross Profit

$930,95457.2% margin

Operating Income

-$35M-2155.0% margin

Net Income

-$34M-2104.0% margin

EPS (Diluted)

$-7.00

QoQ Revenue Growth

-6.3%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

-$17M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$317M

Total Liabilities

$49M

Stockholders' Equity

$268M

Cash & Equivalents

$283M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+0.1%
Gross Profit	$930,954	$2M	-42.3%
Operating Income	-$35M	-$17M	-110.9%
Net Income	-$34M	-$16M	-108.9%